https://doi.org/10.4081/monaldi.2023.2617
Venous thromboembolism and major bleeding in severe and critical COVID-19 hospitalized patients
Submitted: April 24, 2023
Accepted: June 7, 2023
Published: July 5, 2023
Accepted: June 7, 2023
Abstract Views: 967
PDF: 127
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Venous thromboembolism (VTE) and major bleeding (MB) are life-threatening complications described in COVID-19 hospitalized patients, and they can be considered two sides of the same coin. This retrospective study aims to evaluate the risk factors for VTE and MB in COVID-19 patients admitted to two Italian hospitals. The medical records of all COVID-19 patients (males 139; 62.3%, mean age 67.2±13.6 years, body weight 88.2±20.6 kg) hospitalized from March 11th to July 31st, 2020, at the Federico II University Hospital and the Sea Hospital, Naples, Italy, were analyzed. The COVID-19 patients were classified into four groups: COVID-19 patients developing VTE and/or MB, COVID-19 patients developing only VTE, COVID-19 patients developing only MB, and COVID-19 patients not developing either VTE or MB. During the hospitalization, 53 COVID-19 patients (24.7%; males 40; 75.5%, mean age 67.2±13.6 years, weight 88.2±20.6 kg) developed VTE, 33 COVID-19 patients (15.3%; males 17; 51.5, mean age 67.3±14.9 years, weight 74.1±14.3 kg) developed MB, and 129 COVID-19 patients did not develop either TVP or MB. No parameters to identify severe COVID-19 complicated by VTE and/or MB were found. However, some clinical and biochemical parameters can be evaluated to predict the risk of MB in order to modify the treatment and take prompt action to reduce mortality.
Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514-23.
World Health Organization. COVID-19 dashboard. Available from: https://covid19.who.int/.
Gattinoni L, Gattarello S, Steinberg I, et al. COVID-19 pneumonia: pathophysiology and management. Eur Resp Rev 2021;30:210138.
Marietta M, Coluccio V, Luppi M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med 2020;15:1375-87.
Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020;91:9-14.
Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care 2020;46:1089-98.
Fraissé M, Logre E, Pajot O, et al. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study. Crit Care 2020;24:275.
Henderson SR, Salama AD. Haemorrhage and thrombosis: tackling two sides of a single vasculitic disease. Nephrol Dial Transplant 2012;27:4243-4.
Xu SW, Ilyas I, Weng JP. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin 2023;44:695-709.
Tufano A, Rendina D, Abate V, et al Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: a systematic review with meta-analysis. J Clin Med 2020;10:4925.
Shah A, Donovan K, McHugh A, et al. Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study. Crit Care 2020;24:561.
Abate V, Casoria A, Rendina D, et al. Spontaneous muscle hematoma in patients with COVID-19: a systematic literature review with description of an additional case series. Semin Thromb Hemost 2021;48:100-8.
Deitelzweig S, Luo X, Nguyen JL, et al. Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study. J Thromb Thrombolysis 2022;53:766-76.
Willan J, Agarwal G, Bienz N. Mortality and burden of post-COVID-19 syndrome have reduced with time across SARS-CoV-2 variants in haematology patients. Br J Haematol 2023;201:640-4.
Agenzia Nazionale per i Servizi Sanitari Regionali. Criteri di appropriatezza per i setting assistenziali di gestione ospedaliera dei pazienti affetti da COVID-19 – Ver. 2.0. Available from: https://www.agenas.gov.it/images/agenas/covid-19/Appropriatezza_setting_ospedalieri__COVID_2.0_17_6_2021.pdf. [Text in Italian].
World Health Organization. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: interim guidance, 19 March 2020. Available from: https://apps.who.int/iris/handle/10665/331501.
Huisman MV, Klok FA. Diagnostic management of acute deep vein thrombosis and pulmonary embolism. J Thromb Haemost 2013;11:412-22.
Dronkers CE, Klok FA, Huisman MV. Current and future perspectives in imaging of venous thromboembolism. J Thromb Haemost 2016;14:1696-710.
Kaatz S, Ahmad D, Spyropoulos AC, et al. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 2015;13:2119-26.
Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J 2022;19:92.
Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020;18:844-7.
Chen R, Lan Z, Ye J, et al. Cytokine storm: the primary determinant for the pathophysiological evolution of COVID-19 deterioration. Front Immunol 2021;12:589095.
Aires RB, Soares AASM, Gomides APM, et al. Thromboelastometry demonstrates endogenous coagulation activation in nonsevere and severe COVID-19 patients and has applicability as a decision algorithm for intervention. PLoS One 2022;17:e0262600.
Burn E, Duarte-Salles T, Fernandez-Bertolin S, et al. Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect Dis 2022;22:1142-52.
Altschul DJ, Unda SR, de La Garza Ramos R, et al. Hemorrhagic presentations of COVID-19: risk factors for mortality. Clin Neurol Neurosurg 2020;198:106112.
Katsoularis I, Fonseca-Rodríguez O, Farrington P, et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ 2022;377:e069590.
How to Cite
Abate, Veronica, Anita Vergatti, Aniello Casoria, Aquilino Flavio Zarrella, Riccardo Muscariello, Vincenzo Nuzzo, Maria Vargas, et al. 2023. “Venous Thromboembolism and Major Bleeding in Severe and Critical COVID-19 Hospitalized Patients”. Monaldi Archives for Chest Disease 94 (2). https://doi.org/10.4081/monaldi.2023.2617.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Marzia Vassalini, Andrea Verzeletti, Francesco De Ferrari, Standard of care and guidelines in prevention and diagnosis of venous thromboembolism: medico-legal implications , Monaldi Archives for Chest Disease: Vol. 84 No. 1-2 (2015): Cardiac series
- Halil Yanardag, Cuneyt Tetikkurt, Muammer Bilir, Clinical and prognostic significance of muscle biopsy in sarcoidosis , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
- Mara Paneroni, Francesco D' Abrosca, Georges Fokom, Laura Comini, Michele Vitacca, Volitional rehabilitative assessments in patients admitted in a post-intensive care step down unit. A feasibility study , Monaldi Archives for Chest Disease: Vol. 87 No. 1 (2017)
- J.P. Heinzmann-Filho, P.J.C. Marostica, M.V.F. Donadio, Ventilatory muscle strength in cystic fibrosis patients: a literature review , Monaldi Archives for Chest Disease: Vol. 77 No. 3-4 (2012): Pulmonary series
- Neeta Singla, Amitesh Gupta, U.K. Khalid, Ravindra Kumar Dewan, Rupak Singla, Clinical profile, risk factors, disease severity, and outcome for COVID-19 disease in patients with tuberculosis on treatment under the National Tuberculosis Elimination Program: a cohort of 1400 patients , Monaldi Archives for Chest Disease: Early Access
- Francesco Giallauria, Lucrezia Piccioli, Giuseppe Vitale, Filippo M. Sarullo, Exercise training in patients with chronic heart failure: A new challenge for Cardiac Rehabilitation Community , Monaldi Archives for Chest Disease: Vol. 88 No. 3 (2018)
- Francesco Giallauria, Antonio Cittadini, Neil Andrew Smart, Carlo Vigorito, Resistance training and sarcopenia , Monaldi Archives for Chest Disease: Vol. 84 No. 1-2 (2015): Cardiac series
- M. Vitacca, B. Lanini, S. Nava, L. Barbano, R. Porta, E. Clini, N. Ambrosino, Inspiratory muscle workload due to dynamic intrinsic PEEP in stable COPD patients: effects of two different settings of non-invasive pressure-support ventilation , Monaldi Archives for Chest Disease: Vol. 61 No. 2 (2004): Pulmonary series
- J.W. Fitting, Volitional assessment of respiratory muscle strength , Monaldi Archives for Chest Disease: Vol. 77 No. 1 (2012): Pulmonary series
- A. Chetta, M. Aiello, P. Tzani, D. Olivieri, Assessment and monitoring of ventilatory function and cough efficacy in patients with amyotrophic lateral sclerosis , Monaldi Archives for Chest Disease: Vol. 67 No. 1 (2007): Pulmonary series
You may also start an advanced similarity search for this article.
